pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).
| Name | CD2_BENIGN_ENDOCRINE_PANCREAS |
|---|---|
| Long name | Benign neoplasm: Endocrine pancreas |
| Hospital Discharge registry | ICD-10: D137 |
| Cause of Death registry | ICD-10: D137 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Neoplasma benignum partis endocrinae pancreatis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 55 | 24 | 31 |
| Unadjusted prevalence (%) | 0.03 | 0.02 | 0.03 |
| Mean age at first event (years) | 59.18 | 51.05 | 65.47 |
| Case fatality at 5-years (%) | 3.64 | 8.33 | 0.00 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 40.00 | 37.50 | 41.94 |
before Benign neoplasm: Endocrine pancreas
after Benign neoplasm: Endocrine pancreas
Loading survival analyses plot…
Loading survival analyses table…